Predictive Value of Interim [18F]Fluorodeoxyglucose–Positron Emission Tomography in Advanced-Stage Hodgkin Lymphoma Is Not Well Established-Reference-Cited by-同舟云学术

Predictive Value of Interim [18F]Fluorodeoxyglucose–Positron Emission Tomography in Advanced-Stage Hodgkin Lymphoma Is Not Well Established

Published:2017-01-20 Issue:3 Volume:35 Page:370-371
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Adams Hugo J.A.¹,Kwee Thomas C.¹

Affiliation:

1. Hugo J.A. Adams, University Medical Center Utrecht, Utrecht, the Netherlands; and Thomas C. Kwee, University Medical Center Groningen, Groningen, the Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.68.1494

Reference10 articles.

1. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose–Positron Emission Tomography Imaging: Southwest Oncology Group S0816

2. Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis

3. The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

4. Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

5. Importance of Histologic Verification of Positive Positron Emission Tomography/Computed Tomography Findings in the Follow-Up of Patients With Malignant Lymphoma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies;Cochrane Database of Systematic Reviews;2020-01-13

2. Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies;Cochrane Database of Systematic Reviews;2019-09-16

3. Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma;European Journal of Nuclear Medicine and Molecular Imaging;2017-07-14

4. Reply: Interim PET in Hodgkin Lymphoma: Is It So Useless?;Journal of Nuclear Medicine;2017-03-09

5. Reply to H.J.A. Adams et al, E.A. Hawkes et al, and C.F. Hess et al;Journal of Clinical Oncology;2017-01-20